Genomics-Driven Clinical Trials

THURSDAY, NOVEMBER 15, 08:30 ~ 10:10 | Crystal Ballroom

  • Elaine R. Mardis USA

    Nationwide Children's Hospital

  • Yoon-Koo Kang Korea

    University of Ulsan College of Medicine

  • 8:30 ~ 8:55

    Precision medicine in lung cancer : Prime time

    Myung-Ju Ahn Korea

    Sungkyunkwan University Samsung Medical Center

    CV
  • 8:55 ~ 9:20

    The Umbrella Trial in GC: Understanding the disease through genomics

    Jeeyun Lee Korea

    Sungkyunkwan University Samsung Medical Center

    CV
  • 9:20 ~ 9:45

    Tumor agnostic drug development: Revisiting the score card in 2018

    Alexander E. Drilon USA

    Memorial Sloan Kettering Cancer Center

    CV
  • 9:45 ~ 10:10

    Overview of genomic technologies

    Elaine R. Mardis USA

    Nationwide Children's Hospital

    CV

Opening Keynote Lecture

THURSDAY, NOVEMBER 15, 10:40 ~ 11:20 | Crystal Ballroom

  • Charles L. Sawyers USA

    Memorial Sloan Kettering Cancer Center

  • 10:40 ~ 11:20

    Precision medicine in lung cancer: Opportunities & challenges

    Waun Ki Hong USA

    The University of Texas MD Anderson Cancer Center

Luncheon Symposium 1 (ONO Pharma Korea/BMS Korea)

THURSDAY, NOVEMBER 15, 11:20 ~ 11:50 | Crystal Ballroom

  • Geon Kook Lee Korea

    National Cancer Center

  • 11:20 ~ 11:50

    Tumor mutational burden as a predictive biomarker in immuno-oncology: Implications for clinical practice and worldwide implementation

    Aurora Seminara USA

    Bristol-Myers Squibb

    CV

Luncheon Symposium 2(AstraZeneca)

THURSDAY, NOVEMBER 15, 11:20 ~ 12:00 | Emerald Room

  • Sang-We Kim Korea

    University of Ulsan College of Medicine

  • 11:20 ~ 12:00

    Optimal strategy to manage T790M mutant NSCLC patients : from diagnosis to treatment

    Hye Ryun Kim Korea

    Yonsei University College of Medicine

    CV

Luncheon Symposium 3(Merck Korea)

THURSDAY, NOVEMBER 15, 11:20 ~ 12:00 | Sapphire Room

  • Young Suk Park Korea

    Samsung Medical Center

  • 11:20 ~ 12:00

    Optimized treatment strategy in RASwt mCRC with recent precision medicine

    Myung Ah Lee Korea

    Seoul St. Mary's Hospital, The Catholic University of Korea

Special Panel Discussion 1:"Scientia potentia est"-NGS-based precision medicine

THURSDAY, NOVEMBER 15, 12:00 ~ 13:00 | Crystal Ballroom

  • Yeul Hong Kim Korea

    Korea University College of Medicine

  • 12:00 ~ 12:15

    K-MASTER Program overview: Korean Precision Medicine Initiative

    Yeul Hong Kim Korea

    Korea University College of Medicine

    CV
  • 12:15 ~ 12:30

    QuIP TMB Technical Comparability Study – the German approach​

    Jörg Maas Germany

    Qualitätssicherungs-Initiative Pathologie

    CV
  • 12:30 ~ 13:00

    Discussion and Q&A: Regulatory consideration for NGS Oncopanel development

    Aurora Seminara USA

    Bristol-Myers Squibb

    CV
  • 12:30 ~ 13:00

    Discussion and Q&A: Regulatory consideration for NGS Oncopanel development

    Yeul Hong Kim Korea

    Korea University College of Medicine

    CV
  • 12:30 ~ 13:00

    Discussion and Q&A: Regulatory consideration for NGS Oncopanel development

    Jörg Maas Germany

    Qualitätssicherungs-Initiative Pathologie

    CV
  • 12:30 ~ 13:00

    Discussion and Q&A: Regulatory consideration for NGS Oncopanel development

    Sejin Jang Korea

    Asan Medical Center

PS01. Cancer Genomics

THURSDAY, NOVEMBER 15, 13:00 ~ 14:40 | Crystal Ballroom

  • Hyun Cheol Chung Korea

    Yonsei University College of Medicine

  • Patrick Tan Singapore

    Duke-NUS Medical School

  • 13:00 ~ 13:25

    Knowledge to practice using cancer genomics

    Se-Hoon Lee Korea

    Samsung Medical Center

    CV
  • 13:25 ~ 13:50

    Genomic and epigenomic profiles of Asian gastrointestinal malignancies

    Patrick Tan Singapore

    Duke-NUS Medical School

    CV
  • 13:50 ~ 14:15

    Identification of genomic features that can predict the response to chemotherapy using patient-derived xenograft models

    Jong-Il Kim Korea

    Seoul National University College of Medicine

    CV
  • 14:15 ~ 14:40

    Implementing cancer genomics into the diagnosis and treatment of pediatric cancer

    Elaine R. Mardis USA

    Nationwide Children's Hospital

    CV

PS02. Precision Diagnostics: NGS-based Cancer Panels

THURSDAY, NOVEMBER 15, 15:00 ~ 16:40 | Crystal Ballroom

  • Thomas D. Brown USA

    Swedish Cancer Institute

  • Eun Sook Lee Korea

    National Cancer Center Korea

  • 15:00 ~ 15:25

    Current status of the Korean Cancer Precision Medicine Project, K-MASTER

    Yeul Hong Kim Korea

    Korea University College of Medicine

    CV
  • 15:25 ~ 15:50

    Impact of clinical NGS: Lessons from lung cancer

    Jessica Jiyeong Lin USA

    Massachusetts General Hospital Cancer Center

    CV
  • 15:50 ~ 16:15

    Updated results and new studies in the nation-wide NGS-based new agent development

    Atsushi Ohtsu Japan

    National Cancer Center Hospital East

    CV
  • 16:15 ~ 16:40

    The future of cancer care through biologic profiling and big data

    Thomas D. Brown USA

    Swedish Cancer Institute

    CV

Spotlight on Proffered Papers Session 1

THURSDAY, NOVEMBER 15, 16:40 ~ 17:10 | Crystal Ballroom

  • Tae Won Kim Korea

    University of Ulsan College of Medicine

  • Jessica Jiyeong Lin USA

    Massachusetts General Hospital Cancer Center

  • 16:40 ~ 16:50

    Targeted sequencing analysis of pulmonary adenocarcinoma with multiple synchronous ground-glass/lepidic nodules

    Eunhyang Park Korea

    Seoul National University College of Medicine

  • 16:50 ~ 17:00

    Mechanisms of gene fusion formation in bone and soft tissue tumors

    Nathaniel Anderson Canada

    The Hospital for Sick Children, Toronto

  • 17:00 ~ 17:10

    TET1-mediated 5-hydroxymethylcytosine alteration in the pathogenesis of medulloblastoma

    Hyerim Kim USA

    Emory University

Poster Session 1

THURSDAY, NOVEMBER 15, 17:15 ~ 19:30 | Sapphire Room